Mirobio Ltd

Our mission at MiroBio is to deliver transformational immunotherapies for people suffering from autoimmune disease. Immune imbalance is at the heart of many conditions which are marked by an attack on the body’s own cells. MiroBio is advancing a new class of therapies designed to restore immune balance – or homeostasis – and potentially provide durable remission from these chronic, complex conditions. To achieve this, MiroBio has built deep expertise in an emerging area of immunology: precise activation of inhibitory pathways to restore healthy immune function. Our pipeline of agonistic antibodies and supporting platform are informed by over a decade of foundational research. MiroBio draws upon a transatlantic team of advisers, drug developers and leading healthcare investors to further its leadership in this vast new area of immunology.